D-1080-2019 Class III Terminated

Recalled by Akorn, Inc. — Lake Forest, IL

FDA drug recall D-1080-2019 was initiated by Akorn, Inc. on Mar 28, 2019 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing. The recall status is terminated (terminated Apr 22, 2020). Affected quantity: 2,796 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 10, 2019
Initiation Date
Mar 28, 2019
Termination Date
Apr 22, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,796 bottles

Product description

Nystatin Oral Suspension, USP, 100,000 units per mL, 473 mL per bottle, Rx only, HI-TECH Pharmacal Co., Inc., Amityville, NY 11701, NDC 50383-587-16

Reason for recall

Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.

Distribution pattern

AR and MS

Code information

Lot#: 356527, Exp 3/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1080-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1080-2019. Report a data issue: hello@regdatalab.com.